Matches in SemOpenAlex for { <https://semopenalex.org/work/W3025115198> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W3025115198 endingPage "158" @default.
- W3025115198 startingPage "150" @default.
- W3025115198 abstract "Rosacea is a chronic skin condition characterized by persistent central facial erythema. To explore the burden of illness of rosacea in US adults, a cross-sectional web-based survey was conducted. Participants answered questions on sociodemographics, clinical characteristics, bothersome symptoms, coping and avoidance behaviors, self-perceptions, and health care resource utilization, and completed 2 quality of life instruments, the 21-item rosacea-specific quality of life questionnaire (RosaQoL) and the 36-item Short Form Health Survey (SF-36). This paper reports the data from the 409 respondents with erythematotelangiectatic rosacea (ETR), analyzed by erythema severity. Mean age was 53.1 years; mild, moderate, or severe erythema was reported by 63.6%, 32.0%, and 4.4% of participants, respectively. Blushing/flushing and bumps/pustules were the most bothersome symptoms across severity subgroups. Participants in all subgroups coped with rosacea by applying make-up and managing their stress and anxiety, and tried to prevent rosacea flares by avoiding sun exposure, specific skin care products, and other triggers. Self-perceptions differed by severity subgroup: satisfaction with facial appearance significantly decreased, and worrying about how people will react and feelings of unattractiveness to others significantly increased, with greater erythema severity (all P less than 0.01). Treatment or assessment of rosacea was sought by 20% of participants in the past 3 months, most commonly from a dermatologist. Metronidazole was the most frequently prescribed topical product across severity subgroups, whereas doxycycline and other oral antibiotics were prescribed most frequently in the severe erythema subgroup. RosaQoL emotional domain scores increased with erythema severity (P equals 0.0035), but none of the SF-36 domain scores differed significantly by erythema severity. These results demonstrate that rosacea is associated with a substantial burden of illness that spans all levels of erythema severity in patients with ETR. Feelings of unattractiveness and the adverse impact of rosacea on emotional quality of life increased with erythema severity. J Drugs Dermatol. 2018;17(2):150-158." @default.
- W3025115198 created "2020-05-21" @default.
- W3025115198 creator A5007581860 @default.
- W3025115198 creator A5029097859 @default.
- W3025115198 creator A5049756958 @default.
- W3025115198 date "2018-02-01" @default.
- W3025115198 modified "2023-09-29" @default.
- W3025115198 title "Cross-Sectional Survey of the Burden of Illness of Rosacea by Erythema Severity." @default.
- W3025115198 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29462222" @default.
- W3025115198 hasPublicationYear "2018" @default.
- W3025115198 type Work @default.
- W3025115198 sameAs 3025115198 @default.
- W3025115198 citedByCount "4" @default.
- W3025115198 countsByYear W30251151982019 @default.
- W3025115198 countsByYear W30251151982021 @default.
- W3025115198 countsByYear W30251151982023 @default.
- W3025115198 crossrefType "journal-article" @default.
- W3025115198 hasAuthorship W3025115198A5007581860 @default.
- W3025115198 hasAuthorship W3025115198A5029097859 @default.
- W3025115198 hasAuthorship W3025115198A5049756958 @default.
- W3025115198 hasConcept C118552586 @default.
- W3025115198 hasConcept C126322002 @default.
- W3025115198 hasConcept C142052008 @default.
- W3025115198 hasConcept C142724271 @default.
- W3025115198 hasConcept C159110408 @default.
- W3025115198 hasConcept C16005928 @default.
- W3025115198 hasConcept C2777673923 @default.
- W3025115198 hasConcept C2778081122 @default.
- W3025115198 hasConcept C2779121184 @default.
- W3025115198 hasConcept C2779951463 @default.
- W3025115198 hasConcept C2780564577 @default.
- W3025115198 hasConcept C30036603 @default.
- W3025115198 hasConcept C558461103 @default.
- W3025115198 hasConcept C71924100 @default.
- W3025115198 hasConceptScore W3025115198C118552586 @default.
- W3025115198 hasConceptScore W3025115198C126322002 @default.
- W3025115198 hasConceptScore W3025115198C142052008 @default.
- W3025115198 hasConceptScore W3025115198C142724271 @default.
- W3025115198 hasConceptScore W3025115198C159110408 @default.
- W3025115198 hasConceptScore W3025115198C16005928 @default.
- W3025115198 hasConceptScore W3025115198C2777673923 @default.
- W3025115198 hasConceptScore W3025115198C2778081122 @default.
- W3025115198 hasConceptScore W3025115198C2779121184 @default.
- W3025115198 hasConceptScore W3025115198C2779951463 @default.
- W3025115198 hasConceptScore W3025115198C2780564577 @default.
- W3025115198 hasConceptScore W3025115198C30036603 @default.
- W3025115198 hasConceptScore W3025115198C558461103 @default.
- W3025115198 hasConceptScore W3025115198C71924100 @default.
- W3025115198 hasIssue "2" @default.
- W3025115198 hasLocation W30251151981 @default.
- W3025115198 hasOpenAccess W3025115198 @default.
- W3025115198 hasPrimaryLocation W30251151981 @default.
- W3025115198 hasRelatedWork W140508764 @default.
- W3025115198 hasRelatedWork W2004565454 @default.
- W3025115198 hasRelatedWork W2046869281 @default.
- W3025115198 hasRelatedWork W2109615536 @default.
- W3025115198 hasRelatedWork W2121126031 @default.
- W3025115198 hasRelatedWork W2124252059 @default.
- W3025115198 hasRelatedWork W2345467996 @default.
- W3025115198 hasRelatedWork W2417573846 @default.
- W3025115198 hasRelatedWork W2771798643 @default.
- W3025115198 hasRelatedWork W3156955667 @default.
- W3025115198 hasVolume "17" @default.
- W3025115198 isParatext "false" @default.
- W3025115198 isRetracted "false" @default.
- W3025115198 magId "3025115198" @default.
- W3025115198 workType "article" @default.